This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Cerebral palsy

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Cerebral palsy is a persistent qualitative motor disorder which appears before age three and is due to non-progressive damage to the brain.

  • cerebral palsies of childhood are predominantly motor syndromes, not diseases, caused by a variety of pathologies. There is an abnormality of movement or posture and tone which is usually not progressive but is commonly associated with sensory abnormalities, cognitive deficits and epilepsy

Cerebral palsy is the most common cause of physical disability in children and young people in the developed world, with a prevalence of around 2 to 2.5 per 1,000

  • the term describes a group of permanent, non-progressive abnormalities of the developing fetal or neonatal brain that lead primarily to disorders of movement and posture, causing 'activity limitation' and 'functional impact'.

The interaction of primary neurological and secondary physiological factors leads to challenges in terms of both early recognition of cerebral palsy and lifelong management for the person and their families. Children with cerebral palsy generally present to services in 1 of 2 ways:

  • either by identification of atypical motor patterns in those considered at high risk because of antenatal or perinatal complications, or
  • because of atypical motor development picked up during background population assessment

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.